These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1745 related articles for article (PubMed ID: 35012533)

  • 1. Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis.
    Bouras E; Karhunen V; Gill D; Huang J; Haycock PC; Gunter MJ; Johansson M; Brennan P; Key T; Lewis SJ; Martin RM; Murphy N; Platz EA; Travis R; Yarmolinsky J; Zuber V; Martin P; Katsoulis M; Freisling H; Nøst TH; Schulze MB; Dossus L; Hung RJ; Amos CI; Ahola-Olli A; Palaniswamy S; Männikkö M; Auvinen J; Herzig KH; Keinänen-Kiukaanniemi S; Lehtimäki T; Salomaa V; Raitakari O; Salmi M; Jalkanen S; ; Jarvelin MR; Dehghan A; Tsilidis KK
    BMC Med; 2022 Jan; 20(1):3. PubMed ID: 35012533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between genetically predicted concentrations of circulating inflammatory cytokines and the risk of ten pregnancy-related adverse outcomes: A two-sample Mendelian randomization study.
    Chen X; Zhang M; Zhou N; Zhou W; Qi H
    Cytokine; 2024 Aug; 180():156661. PubMed ID: 38795606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study.
    Morales Berstein F; McCartney DL; Lu AT; Tsilidis KK; Bouras E; Haycock P; Burrows K; Phipps AI; Buchanan DD; Cheng I; ; Martin RM; Davey Smith G; Relton CL; Horvath S; Marioni RE; Richardson TG; Richmond RC
    Elife; 2022 Mar; 11():. PubMed ID: 35346416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between cytokines and the risk of female and male infertility: A two-sample Mendelian randomization analysis.
    Zhang L; Li H; Wu Z; Han L; Zhang J
    J Reprod Immunol; 2024 Jun; 163():104238. PubMed ID: 38479056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.
    Yarmolinsky J; Robinson JW; Mariosa D; Karhunen V; Huang J; Dimou N; Murphy N; Burrows K; Bouras E; Smith-Byrne K; Lewis SJ; Galesloot TE; Kiemeney LA; Vermeulen S; Martin P; Albanes D; Hou L; Newcomb PA; White E; Wolk A; Wu AH; Le Marchand L; Phipps AI; Buchanan DD; ; ; Zhao SS; Gill D; Chanock SJ; Purdue MP; Davey Smith G; Brennan P; Herzig KH; Järvelin MR; Amos CI; Hung RJ; Dehghan A; Johansson M; Gunter MJ; Tsilidis KK; Martin RM
    EBioMedicine; 2024 Feb; 100():104991. PubMed ID: 38301482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating phosphorus concentration and risk of prostate cancer: a Mendelian randomization study.
    Lv L; Ye D; Chen J; Qian Y; Fu AN; Song J; Yang H; Liu B; Sun X; Du L; Mao Y
    Am J Clin Nutr; 2022 Feb; 115(2):534-543. PubMed ID: 34617559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between circulating inflammatory factors and autism spectrum disorder: a bidirectional Mendelian randomization study in European population.
    Long J; Dang H; Su W; Moneruzzaman M; Zhang H
    Front Immunol; 2024; 15():1370276. PubMed ID: 38742104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically Predicted Circulating Levels of Cytokines and the Risk of Cancer.
    Song J; Li A; Qian Y; Liu B; Lv L; Ye D; Sun X; Mao Y
    Front Immunol; 2022; 13():886144. PubMed ID: 35865545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
    Yarmolinsky J; Bouras E; Constantinescu A; Burrows K; Bull CJ; Vincent EE; Martin RM; Dimopoulou O; Lewis SJ; Moreno V; Vujkovic M; Chang KM; Voight BF; Tsao PS; Gunter MJ; Hampe J; Pellatt AJ; Pharoah PDP; Schoen RE; Gallinger S; Jenkins MA; Pai RK; ; ; Gill D; Tsilidis KK
    Diabetologia; 2023 Aug; 66(8):1481-1500. PubMed ID: 37171501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating vitamin C concentration and risk of cancers: a Mendelian randomization study.
    Fu Y; Xu F; Jiang L; Miao Z; Liang X; Yang J; Larsson SC; Zheng JS
    BMC Med; 2021 Jul; 19(1):171. PubMed ID: 34325683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of the circulating levels of cytokines with the risk of myeloproliferative neoplasms: a bidirectional mendelian-randomization study.
    Xiong H; Zhang H; Bai J; Li Y; Li L; Zhang L
    BMC Cancer; 2024 Apr; 24(1):531. PubMed ID: 38671390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causal association of circulating cytokines with sepsis: a Mendelian randomization study.
    Lin S; Mao X; He W
    Front Immunol; 2023; 14():1281845. PubMed ID: 37915587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis.
    Yarmolinsky J; Díez-Obrero V; Richardson TG; Pigeyre M; Sjaarda J; Paré G; Walker VM; Vincent EE; Tan VY; Obón-Santacana M; Albanes D; Hampe J; Gsur A; Hampel H; Pai RK; Jenkins M; Gallinger S; Casey G; Zheng W; Amos CI; ; ; ; Smith GD; Martin RM; Moreno V
    PLoS Med; 2022 Feb; 19(2):e1003897. PubMed ID: 35113855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of the circulating levels of cytokines with risk of amyotrophic lateral sclerosis: a Mendelian randomization study.
    Liu B; Lyu L; Zhou W; Song J; Ye D; Mao Y; Chen GB; Sun X
    BMC Med; 2023 Feb; 21(1):39. PubMed ID: 36737740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of genetically predicted circulating levels of cytokines with telomere length: a Mendelian randomization study.
    Pan R; Xiao M; Wu Z; Liu J; Wan L
    Front Immunol; 2023; 14():1276257. PubMed ID: 37942318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Inflammatory Cytokines and Female Reproductive Diseases: A Mendelian Randomization Analysis.
    Lin Y; Wang G; Li Y; Yang H; Zhao Y; Liu J; Mu L
    J Clin Endocrinol Metab; 2023 Nov; 108(12):3154-3164. PubMed ID: 37350485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial related genome-wide Mendelian randomization identifies putatively causal genes for multiple cancer types.
    Li Y; Sundquist K; Zhang N; Wang X; Sundquist J; Memon AA
    EBioMedicine; 2023 Feb; 88():104432. PubMed ID: 36634566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis.
    Yarmolinsky J; Relton CL; Lophatananon A; Muir K; Menon U; Gentry-Maharaj A; Walther A; Zheng J; Fasching P; Zheng W; Yin Ling W; Park SK; Kim BG; Choi JY; Park B; Davey Smith G; Martin RM; Lewis SJ
    PLoS Med; 2019 Aug; 16(8):e1002893. PubMed ID: 31390370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the association between the circulating levels of inflammatory cytokines and the risk of tuberculosis: A bidirectional two-sample mendelian randomization study.
    Zhang SX; Lu ZH; Wang MT; Shen YP; Duan L; Guan SY; Chen MX; Lu Y; Yang M; Wang L; Yang GB; Lv WW; Wang JC; Zheng JX
    Infect Genet Evol; 2023 Dec; 116():105524. PubMed ID: 37952650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring causal correlations between inflammatory cytokines and systemic lupus erythematosus: A Mendelian randomization.
    Xiang M; Wang Y; Gao Z; Wang J; Chen Q; Sun Z; Liang J; Xu J
    Front Immunol; 2022; 13():985729. PubMed ID: 36741410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 88.